Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Genotype 4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT01125189
What this trial is testing

Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 558
Large-scale testing (Phase 3)Study completedNCT02446717
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV+1 more
AbbVie 141
Post-approval studies (Phase 4)Study completedNCT00277862
What this trial is testing

Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Who this might be right for
Hepatitis C
Ain Shams University 280
Not applicableStudy completedNCT04048850
What this trial is testing

Zepatier in Patients with Substance Use

Who this might be right for
Hepatitis CHivCoinfection, HIV+1 more
University of Illinois at Chicago 25
Not applicableUnknownNCT02772744
What this trial is testing

Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4

Who this might be right for
Hepatitis C
Zagazig University 250
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Post-approval studies (Phase 4)Study completedNCT02128542
What this trial is testing

Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 66
Testing effectiveness (Phase 2)Study completedNCT01057667
What this trial is testing

RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 168
Large-scale testing (Phase 3)Study completedNCT02105701
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)

Who this might be right for
Hepatitis C Infection
Merck Sharp & Dohme LLC 420
Large-scale testing (Phase 3)Study completedNCT02105688
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 301
Testing effectiveness (Phase 2)Study completedNCT01932762
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 98
Testing effectiveness (Phase 2)WithdrawnNCT02309450
What this trial is testing

Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen

Who this might be right for
Hepatitis C Virus Genotype 4 Infection
ANRS, Emerging Infectious Diseases
Large-scale testing (Phase 3)WithdrawnNCT01871662
What this trial is testing

Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Rottapharm
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Testing effectiveness (Phase 2)Study completedNCT01782495
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 129
Large-scale testing (Phase 3)WithdrawnNCT01447394
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770984
What this trial is testing

Treatment of CKD Patients With HCV

Who this might be right for
HCV Infection ( Genotype 4) in CKD Patients
Tanta University 50
Large-scale testing (Phase 3)Study completedNCT02642432
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis
AbbVie 146
Next Page